Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.
|
|
|
|
|
11-50 employees
View all Neuspera Medical Inc. employees
|
|
|
Medical Devices
|
|
|
San Jose, CA
|
|
|
None
|
|
|
Neuromodulation And Neurostimulation
|
Milton M Morris is the CEO of Neuspera Medical Inc.. To contact Milton M Morris email at [email protected].
The decision makers in Neuspera Medical Inc. are Courtney Lane, Jessica Holmes, Josh Cohen, etc. Click to Find Neuspera Medical Inc. decision makers emails.
Neuspera Medical focuses on developing neuromodulation and neurostimulation technologies aimed at treating chronic illnesses. The first intended indication for use is related to urinary conditions, such as overactive bladder and urinary incontinence. These devices work by modulating nerve activity to alleviate symptoms and improve patient quality of life.
Neuspera Medical's implantable devices utilize advanced neuromodulation techniques that target specific nerves to regulate bodily functions, offering a less invasive alternative to traditional treatments like medications or surgeries. These devices are designed to provide long-term relief with fewer side effects, improving patient adherence and overall outcomes.
The implantation process for Neuspera Medical's devices typically involves a minimally invasive procedure performed by a qualified healthcare professional. The device is implanted under the skin and connected to the targeted nerve. The procedure is usually outpatient, allowing patients to return home the same day, and recovery times are generally quick, enabling patients to resume normal activities shortly after.
Yes, Neuspera Medical's devices are designed with patient safety as a top priority. The company adheres to rigorous regulatory standards and is committed to obtaining FDA approval for its products. Clinical trials are conducted to ensure the safety and efficacy of the devices before they are made available to patients.
Neuspera Medical provides comprehensive support to patients after device implantation, including follow-up appointments to monitor device performance and patient health. Additionally, the company offers educational resources to help patients understand how to use their devices effectively and manage their conditions. Patients can also access customer support for any questions or concerns they may have.
Healthcare providers interested in learning more about Neuspera Medical's solutions can visit the company's website for detailed information on their products, clinical studies, and educational resources. Additionally, providers can reach out directly to Neuspera Medical's sales or support teams for personalized assistance and to schedule informational sessions or demonstrations.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.